These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 18383859)
1. Antiangiogenic properties of lupulone, a bitter acid of hop cones. Siegel L; Miternique-Grosse A; Griffon C; Klein-Soyer C; Lobstein A; Raul F; Stephan D Anticancer Res; 2008; 28(1A):289-94. PubMed ID: 18383859 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects. Maffucci T; Piccolo E; Cumashi A; Iezzi M; Riley AM; Saiardi A; Godage HY; Rossi C; Broggini M; Iacobelli S; Potter BV; Innocenti P; Falasca M Cancer Res; 2005 Sep; 65(18):8339-49. PubMed ID: 16166311 [TBL] [Abstract][Full Text] [Related]
3. The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide. Ferrari N; Pfeffer U; Dell'Eva R; Ambrosini C; Noonan DM; Albini A Clin Cancer Res; 2005 Jun; 11(12):4610-9. PubMed ID: 15958647 [TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic activity of beta-eudesmol in vitro and in vivo. Tsuneki H; Ma EL; Kobayashi S; Sekizaki N; Maekawa K; Sasaoka T; Wang MW; Kimura I Eur J Pharmacol; 2005 Apr; 512(2-3):105-15. PubMed ID: 15840394 [TBL] [Abstract][Full Text] [Related]
5. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol. Shibata A; Nakagawa K; Sookwong P; Tsuzuki T; Oikawa S; Miyazawa T Biochem Pharmacol; 2008 Aug; 76(3):330-9. PubMed ID: 18599020 [TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic activity of 11,11'-dideoxyverticillin, a natural product isolated from the fungus Shiraia bambusicola. Chen Y; Zhang YX; Li MH; Zhao WM; Shi YH; Miao ZH; Zhang XW; Lin LP; Ding J Biochem Biophys Res Commun; 2005 Apr; 329(4):1334-42. PubMed ID: 15766573 [TBL] [Abstract][Full Text] [Related]
7. Proapoptotic, antimigratory, antiproliferative, and antiangiogenic effects of commercial C-reactive protein on various human endothelial cell types in vitro: implications of contaminating presence of sodium azide in commercial preparation. Liu C; Wang S; Deb A; Nath KA; Katusic ZS; McConnell JP; Caplice NM Circ Res; 2005 Jul; 97(2):135-43. PubMed ID: 15976313 [TBL] [Abstract][Full Text] [Related]
8. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis. Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806 [TBL] [Abstract][Full Text] [Related]
9. Lebectin, a Macrovipera lebetina venom-derived C-type lectin, inhibits angiogenesis both in vitro and in vivo. Pilorget A; Conesa M; Sarray S; Michaud-Levesque J; Daoud S; Kim KS; Demeule M; Marvaldi J; El Ayeb M; Marrakchi N; Béliveau R; Luis J J Cell Physiol; 2007 May; 211(2):307-15. PubMed ID: 17323383 [TBL] [Abstract][Full Text] [Related]
10. Hypericin in the dark inhibits key steps of angiogenesis in vitro. Martínez-Poveda B; Quesada AR; Medina MA Eur J Pharmacol; 2005 Jun; 516(2):97-103. PubMed ID: 15921677 [TBL] [Abstract][Full Text] [Related]
11. [Study on antiangiogenesis effect of Vaccaria segetalis]. Feng L; Hua H; Qiu LY; Zhang LF; Jin J Zhong Yao Cai; 2009 Aug; 32(8):1256-9. PubMed ID: 19960951 [TBL] [Abstract][Full Text] [Related]
12. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells. Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341 [TBL] [Abstract][Full Text] [Related]
13. Antiangiogenic concentrations of vinflunine increase the interphase microtubule dynamics and decrease the motility of endothelial cells. Pourroy B; Honoré S; Pasquier E; Bourgarel-Rey V; Kruczynski A; Briand C; Braguer D Cancer Res; 2006 Mar; 66(6):3256-63. PubMed ID: 16540678 [TBL] [Abstract][Full Text] [Related]
15. The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis. Carmi Y; Voronov E; Dotan S; Lahat N; Rahat MA; Fogel M; Huszar M; White MR; Dinarello CA; Apte RN J Immunol; 2009 Oct; 183(7):4705-14. PubMed ID: 19752225 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the antiangiogenic potential of AQ4N. O'Rourke M; Ward C; Worthington J; McKenna J; Valentine A; Robson T; Hirst DG; McKeown SR Clin Cancer Res; 2008 Mar; 14(5):1502-9. PubMed ID: 18316575 [TBL] [Abstract][Full Text] [Related]
17. Vascular-specific quantification in an in vivo Matrigel chamber angiogenesis assay. Baker JH; Huxham LA; Kyle AH; Lam KK; Minchinton AI Microvasc Res; 2006 Mar; 71(2):69-75. PubMed ID: 16545400 [TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic properties of viscum album extracts are associated with endothelial cytotoxicity. Elluru SR; Duong Van Huyen JP; Delignat S; Prost F; Heudes D; Kazatchkine MD; Friboulet A; Kaveri SV Anticancer Res; 2009 Aug; 29(8):2945-50. PubMed ID: 19661299 [TBL] [Abstract][Full Text] [Related]
19. Identification of HIV-1 Tat peptides for future therapeutic angiogenesis. Ismail M; Henklein P; Huang X; Braumann C; Rückert RI; Dubiel W Eur J Haematol; 2006 Aug; 77(2):157-65. PubMed ID: 16800839 [TBL] [Abstract][Full Text] [Related]
20. Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: an orally bioavailable heat shock protein 90 modulator. Kaur G; Belotti D; Burger AM; Fisher-Nielson K; Borsotti P; Riccardi E; Thillainathan J; Hollingshead M; Sausville EA; Giavazzi R Clin Cancer Res; 2004 Jul; 10(14):4813-21. PubMed ID: 15269157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]